Purpose. To investigate the distribution of molecular types of methicillin-resistant Staphylococcus aureus (MRSA) in a paediatric intensive care unit (PICU) according to their community-associated (CA) and hospital-associated (HA) source of acquisition, and thus assess the degree to which CA-MRSA has been introduced into the PICU.
INTRODUCTION
Methicillin-resistant Staphylococcus aureus (MRSA) is a major causative agent of infections in paediatric intensive care units (PICUs) [1] . Because of distinctive host and environmental factors, including immature immune systems, frequent use of invasive devices and overcrowding in PICUs, PICU patients are especially susceptible to MRSA colonization and infections [2] . To prevent MRSA transmission within PICUs, active surveillance of MRSA colonization and infections is usually implemented [3] . A surveillance in American PICUs showed that the incidence of late-onset MRSA infections increased from 0.7 to 3.1 infections/10 000 patient-days from 1995 to 2004 [4] . In paediatric hospitals in China, MRSA also remains a common causative agent of infections [5] .
To better understand the transmission sources of MRSA infections, MRSA strains are usually divided into community-associated MRSA (CA-MRSA) and hospital-associated MRSA (HA-MRSA). In terms of multilocus sequence typing (MLST), each type of MRSA has distinct genetic distribution features. CA-MRSA infections are mainly attributed to several major clones -ST1, ST8, ST30 and ST59 [6] whereas HA-MRSA infections are often caused by the ST2470, ST239 and ST5 strains [7] . However, current reports have found that traditional CA-MRSA strains with increased virulence have been introduced into healthcare settings. This situation blurs the community/hospital boundaries between CA-MRSA and HA-MRSA [8, 9] . This blurred boundary also exists in PICUs, with CA-MRSA strains being found in long-stay patients [10] .
The emerging blurred boundaries between CA-MRSA and HA-MRSA indicate that the varying composition of traditional HA-MRSA and CA-MRSA strains in PICUs is ongoing. To assess whether (and to what extent) this blurred boundary exists in a PICU and, if it does, consider how the situation should be interpreted, we implemented MRSA isolation surveillance using pulsed-field gel electrophoresis (PFGE), MLST and spa typing, and tested the antimicrobial resistance and virulence genes of these isolates. Our results demonstrate the predominance of genetically and phenotypically diverse, presumably community-associated, ST59 MRSA in the PICU that we assessed.
METHODS

Study setting and data collection
This study was conducted in Ningbo Women and Children's Hospital, which has 1100 beds and a PICU with 60 beds. The PICU annually admits about 1500 patients under 14 years old. The enrolled patients were hospitalized from January 2013 to December 2016. HA-MRSA cases were defined as patients with any of the following healthcarerelated risk factors: (1) an MRSA infection identified after 2 days of hospitalization; (2) a history of hospitalization, surgery or dialysis, or a history in a long-term care facility within 1 year of the MRSA culture date; (3) a permanent indwelling catheter or percutaneous medical device present at the time of culture; or (4) a known positive culture for MRSA prior to the study period. CA-MRSA cases were defined as patients who appeared to contract MRSA infections and did not have any healthcare-related risk factors based on medical record review and personal interview [11] . MRSA-related infections were defined as cases where MRSA was isolated from sterile sites with clinical signs or symptoms of infection, including fever, elevated white blood cell count and elevated C-reactive protein (CRP), or from non-sterile sites with a clinical infection diagnosis related to the isolation sites. Otherwise, the remaining isolates were assumed to be colonized isolates, and these were mostly from non-sterile sites of patients without a clinical infection diagnosis related to the isolation sites [12] .
Our study included CA-MRSA and HA-MRSA colonization, as well as MRSA infections including skin/musculoskeletal infection, bloodstream infections, ventilatorassociated pneumonias and so on. Ventilator-associated pneumonia was diagnosed if a patient had a new or developing infiltrate on a chest X-ray plus at least two of following criteria: temperature of >38 or <36 C, a leukocyte count of >12Â10 9 ml
À1
, elevated CRP, purulent secretions from airways in the lung and/or reduction in gas exchange [13] . We collected clinical data on the patients' age and length of hospital stay at sampling time. To determine the disease severity in patients suspected of infection, we used the diagnostic criteria for sepsis [14] .
To assess the boundary between CA-MRSA and HA-MRSA, we subtyped defined CA-MRSA and HA-MRSA isolates using PFGE, MLST and spa typing methods. To control adverse factors that might affect the detection rates for isolates over a long study period, we drafted a protocol indicating the sampling process, and ensured that the laboratory joined quality control programmes. All drug resistance testing, genetic typing and virulence gene detection were completed centrally under strict supervision.
Bacterial identification
Staphylococcus aureus (S. aureus) isolates were obtained from specimens such as nasopharyngeal swabs, endotracheal aspirate, blood, pus and surgical site secretions. These isolates were identified using standard laboratory techniques, including Gram stain, the plasma coagulase test and biochemical reaction by Vitek 2 Gram-positive identification card (bioM erieux, Marcy l'Etoile, France). Then, disc diffusion testing on Müller-Hinton agar (BBL, BD) was performed to test the antimicrobial susceptibility of the isolates to penicillin, oxacillin, cefoxitin, tetracycline, ciprofloxacin, gentamicin, erythromycin, clindamycin, tigecycline, rifampin, linezolid, trimethoprim-sulfamethoxazole and vancomycin. MRSA was confirmed according to cefoxitin resistance and the presence of the mecA gene [15] . Each further studied S. aureus isolate was confirmed by PCR detection of the nuc gene [16] .
Molecular typing of MRSA isolates
We first performed MLST typing according to the description on the MLST website (http://saureus.mlst.net/). Then, we performed further subtyping using PFGE by SmaI digestion according to the PulseNet standardized protocol, and using Ridom spa typing by amplifying and sequencing the repeat-containing region of the staphylococcal protein A gene. Ridom spa types were assigned using the SpaServer website (http://spaserver2.ridom.de) as previously described [17] . The staphylococcal cassette chromosome mec (SCCmec) types of MRSA were determined by a multiplex PCR assay [18] .
PCR assays for the detection of virulence genes and the mecA gene To characterize the pathogenicity of the MRSA isolates, we used the PCR primers and conditions previously described to detect 15 virulence genes [19, 20] . These virulence genes included staphylococcal enterotoxin genes (sea, seb, sec, sed, see, seg, seh, sei and sej), toxic shock syndrome toxin (tst), exfoliative toxins (eta and etb), Panton-Valentine leukocidin (pvl), haemolysins (hla and hlb) and the mecA gene. Further, the profiles of the virulence genes and the patterns of antibiotic resistance (antibiogram) were used for phenotypic typing of the MRSA isolates.
Statistical analysis
The mean, median and interquartile ranges (IQR) were calculated for demographic information. Differences between median groups were analysed by the Wilcoxon signed-rank test. Dichotomous variables between groups were compared using the Mantel-Haenszel Chi-squared test using the SPSS 10.0 software package (SPSS, Chicago, IL, USA). Statistical significance for all statistical tests was set to a two-tailed P value of 0.05.
RESULTS
Bacterial isolates
A total of 156 (5.8 %) S. aureus isolates were recovered from 2684 specimens, of which 60 were MRSA ( Table 1) . The overall MRSA detection rate was 2.2 % (60/2684). The median age and length of stay in the PICU for the 156 S. aureus-positive patients were 2 months (IQR, 11 days-11 months) and 8 days (IQR, 5-13 days), respectively. Similarly, the median age and length of stay in the PICU for the 60 MRSA-positive patients were 2 months (IQR, 14 days-12 months; P=0.14) and 9 days (IQR, 5-14 days; P=0.12), respectively. Both the S. aureus and MRSA isolates were recovered primarily from respiration sources, i.e. nasopharyngeal swabs and endotracheal aspirates. There was no apparent trend in the annual isolation numbers for S. aureus and MRSA isolates (Fig. 1 ).
According to the criteria for distinguishing HA-MRSA and CA-MRSA, 51 S. aureus isolates and 20 MRSA isolates were community-associated, and 105 S. aureus isolates and 40 MRSA isolates were hospital-associated. Of the MRSA isolates, 35 were from MRSA-related infections, including ventilator-associated pneumonias (24 cases), skin infections (4 cases), blood infections (4 cases) and surgical site infections (3 cases). The remaining 25 MRSA isolates were from colonized sites. In addition, 85 % of the 60 MRSA cases met the diagnostic criteria for sepsis, which is higher than the figure (58 %) for the 156 S. aureus-positive cases (P<0.001).
MLST, PFGE and spa typing results As many as 72 % (43 isolates) of the 60 MRSA isolates were ST59 MRSA. The remaining 17 isolates belonged to ST1 (5 isolates), ST7 (3 isolates), ST88 (2 isolates), ST398 (4 isolates) and ST965 (3 isolates). To investigate the diversity among the great proportion of ST59 MRSA isolates, PFGE and spa typing were used to further type these isolates. At a Dice coefficient similarity level of 95 %, PFGE was able to divide the 43 ST59 MRSA isolates into a dominant cluster (cluster 1, 29 isolates) and a minor cluster (cluster 2, 7 isolates), as well as 7 sporadic isolates (Fig. 2) 
MRSA isolates, four groups of isolates were generated: G1 (6 isolates), G2 (6 isolates), G3 (17 isolates) and G4 (7 isolates) (Fig. 2) .
Antibiograms
The 43 ST59 MRSA isolates showed varied rates of resistance against four non-b-lactam agents, clindamycin (95 %), erythromycin (95 %), ciprofloxacin (65 %) and tetracycline (9 %). The four antibiograms were clindamycin/ erythromycin/ciprofloxacin (26 isolates), clindamycin/ erythromycin (11 isolates), clindamycin/erythromycin/tetracycline (4 isolates) and ciprofloxacin (2 isolates).
Profiles of virulence genes and SCCmec types
The 43 ST59 MRSA showed a high presence of staphylococcal enterotoxin genes and the hla gene, and a moderate presence of the pvl gene. There were three types of staphylococcal enterotoxin genes, sei (72 %), sea (60 %) and seb (60 %), two types of haemolysin genes, hla (100 %) and hlb (76 %), and also pvl (26 %). Of the other virulence genes that were tested for, including sec, sed, see, seh, sej, tst, eta and etb, none were found. The detected virulence genes were arranged into 12 virulence profiles. The top 2 prevalent profiles were sea-sebsei-hla-hlb (10 isolates) and seb-sei-pvl-hla-hlb (6 isolates). SCCmec typing generated 34 SCCmec-IV isolates (mostly groups G1, G2 and G3) and 9 SCCmec-V isolates (mostly group G4) (Fig. 2) . *If a patient had one of four healthcare-related risk factors as specified in the Methods section, we viewed the specimen as hospital-associated, otherwise it was considered to be community-associated, in line with our categorization of isolates. †Other types of specimens include urine, body fluids and indwelling catheter. ‡Detection rate for number of isolates versus number of specimens in relevant community-associated and hospital-associated groups.
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Assessment of diversity and distribution of ST59 MRSA All of the results showed that ST59 MRSA isolates were genetically and phenotypically diverse in three aspects: the patterns from three molecular typing methods, PFGE, MLST and spa; antibiograms; and virulence profiles. Of these three aspects, the virulence profiles showed the greatest diversity.
Finally, 43 ST59 MRSA isolates were found to be both community-associated (15 isolates) and hospital-associated (28 isolates). These isolates were isolated from different age groups of children and caused colonization and various types of infections (Table 2 ). Judging arbitrarily, we found no apparent discrepancy between the ST59 CA-and HA-MRSA groups in the distribution of isolates with respect to patient age, outcomes, PFGE patterns, spa, antibiograms and virulence profiles.
DISCUSSION
Our results show that genetically and phenotypically diverse (presumably) ST59 CA-MRSA has predominantly colonized PICU patients and caused both community-associated and hospital-associated infections. This blurred boundary has caused the ST59 HA-MRSA and CA-MRSA to be indistinguishable in the PICU.
In this study, ST59 MRSA was found to be community-associated and more hospital-associated and to cause colonization and various types of infections among different age groups of children (Table 2 ) over a 4-year study period (Fig. 1, Table 2 ). This phenomenon suggests a steady transmission of ST59 in healthcare settings. ST59 MRSA is traditionally regarded as a major cause of skin and soft tissue infections in the community, especially in children [21] . When we performed a systematic review of the literature concerning ST59 MRSA using the terms 'ST59 or sequence type 59', and 'MRSA and/or methicillin-resistant Staphylococcus aureus', we found at least 15 papers on PUBMED during 2010-2017 [22, 23] . Most studies concerned community-associated ST59 MRSA. However, in the PICU, we found ST59 MRSA throughout the whole study period, rather than common HA-MRSA lineages such as ST2470, ST239 and ST5, indicating that traditional CA-MRSA has become the major cause of hospital-acquired infections. Our comparison of ST59 CA-MRSA and HA-MRSA also shows a high similarity in genetic features and epidemiological characteristics between ST59 CA-MRSA and HA-MRSA (Table 2) .
Our findings also demonstrate that the dominant ST59 MRSA isolates are genetically and phenotypically diverse, a judgement that is based on moderate PFGE and spa typing diversity (Fig. 2) , four antibiograms and 12 virulence gene profiles. The results reveal that PFGE and spa typing can be used to increase discriminatory capability when typing ST59 MRSA isolates. Based on the number of clusters and sporadic isolates, the virulence profiles show the highest discriminatory power in further typing ST59 MRSA, followed by PFGE, antibiograms and spa typing. However, the PFGE results appear to be the most straightforward. Several researches have also shown that ST59 MRSA consists of two lineages based on different SCCmec and pvl carriage, one pvl-negative SCCmec-IV lineage and another pvl-positive SCCmec-V lineage [21] . These two lineages were also found in our study. The majority of ST59 MRSA are pvl-negative SCCmec-IV (groups G1, G2 and G3) and the minority are pvl-positive SCCmec-V (Group G4) (Fig. 2) . Moreover, there is greater diversity in terms of the three combined typing results, suggesting that there are more distinct lineages of ST59 MRSA than the two lineages previously observed in Chinese children [21, 24] . In addition, the high rates of a number of infection-related virulence factors may enable ST59 MRSA to be more invasive and dangerous, and show greater pathogenicity, which is also supported by the greater proportion of MRSA cases meeting the diagnostic criteria for sepsis compared with S. aureus-positive cases. The carrier rates for both sea (47 %) and seb (47 %) are higher than those in previous studies [sea (68.5 %) and seb (0 %) in Chinese hospital-acquired S. aureus isolates associated with blood-stream infections [25] and sea (5 %) and seb (13 %) in MRSA isolates from an American hospital] [26] . The protein products of sea and seb have potent super-antigenic activities that result in potentially life-threatening stimulation of the immune system [27] . High carrier rates of staphylococcal enterotoxin genes are considered to increase severe MRSA-related infections. The product of pvl is also considered to be an important virulence factor in S. aureus, particularly in MRSA pneumonia [28] .
Finally, when dealing with commonly occurring infections, in which the causative agents focus on very limited clones, e.g. infections by dominant ST59 MRSA, it is challenging to Fig. 2 . Further typing of 43 ST59 MRSA isolates by PFGE, spa and SCCmec typing. Two PFGE clusters (designated as cluster 1 and cluster 2) and three spa types were identified. Combining the three typing methods generated four groups of strains (G1, G2, G3 and G4). The isolates comprised 34 SCCmec-IV isolates (mostly groups G1, G2 and G3) and 9 SCCmec-V isolates (mostly group G4).
interpret such circumstances to distinguish an outbreak from endemic cases. In this study, we integrated the results of genetic typing methods and epidemiological data to derive deeper insights into the true distribution nature. When the dispersed isolates were considered in terms of onset time and typing, the results revealed no apparent clustering trend in S. aureus, MRSA and ST59 MRSA over the study period. Thus, we conclude that the great proportion of ST59 MRSA isolates here are due to a highly dominant MRSA clone for young patients rather than an outbreak.
To summarize, our study shows that ST59 MRSA with genetic and phenotypic diversity is the dominant aetiological agent for community-associated and hospital-associated S. aureus-related infections and colonization in the PICU. This phenomenon suggests that a group of ST59 MRSA may exist within PICU and result in the indistinguishability between ST59 HA-MRSA and CA-MRSA in it. This study also indicates that when we interpret circumstances where the causative agents of infections focus on very limited pathogenic clones, combined typing methods and epidemiological information are imperative to investigate pathogens' genetic and phenotypical diversity to identify an outbreak or endemic cases.
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